The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Open accessAbstract
Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 has been previously identified as a key cytokine that directly induces tumuor growth in CRC via STAT3 activation in IECs.12,15,46,47.”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED AND REPLACED: microRNA involvement in human cancer
Iorio, M. V., & Croce, C. M. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs140 · Cited by 577
RetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citationThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,333
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Jerry, 1993, Cancer Res., 53, 3374
Cited by
Sorted by citations
Items 201–300 of 754
MiR‐34b/c‐5p and the neurokinin‐1 receptor regulate breast cancer cell proliferation and apoptosis
Zhang, L., Wang, L., Dong, D., Wang, Z., Ji, W., Yu, M., Zhang, F., Niu, R., & Zhou, Y. (2018) · Cell Proliferation · doi:10.1111/cpr.12527 · Cited by 55
STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy
Yang, P.-L., Liu, L.-X., Li, E., & Xu, L. (2020) · Cancers · doi:10.3390/cancers12092459 · Cited by 57
Li, T., Guo, H., Zhao, X., Jin, J., Zhang, L., Li, H., Lu, Y., Nie, Y., Wu, K., Shi, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0357 · Cited by 54
Self-citationSong, L., Wang, Y., Zhen, Y.-H., Li, D., He, X., Yang, H. S., Zhang, H., & Liu, Q. (2020) · Biotechnology Letters · doi:10.1007/s10529-020-02923-z · Cited by 54
Fan, L.-C., Teng, H., Shiau, C., Tai, W., Hung, M., Yang, S., Jiang, J., & Chen, K. (2016) · Oncotarget · doi:10.18632/oncotarget.11636 · Cited by 53
Wottrich, S., Kaufhold, S., Chrysos, E., Zoras, O., Baritaki, S., & Bonavida, B. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.01.001 · Cited by 55
miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer
Zhu, X., Ma, S., Yang, D., Liu, Y., Wang, Y., Lin, T., Li, Y., Yang, S., Zhang, W., & Wang, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495721 · Cited by 53
Liu, Y., Zhi, Y., Song, H., Zong, M., Yi, J., Mao, G., Chen, L., & Huang, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1369-7 · Cited by 53
New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer
Caliceti, C., Punzo, A., Silla, A., Simoni, P., Roda, G., & Hrelia, S. (2022) · Nutrients · doi:10.3390/nu14142964 · Cited by 51
Fazio, C., Piazzi, G., Vitaglione, P., Fogliano, V., Munarini, A., Prossomariti, A., Milazzo, M., D’Angelo, L., Napolitano, M., Chieco, P., et al. (2016) · Scientific Reports · doi:10.1038/srep20670 · Cited by 52
Li, G., Yao, L., Zhang, J., Li, X., Dang, S., Zeng, K., Zhou, Y., & Gao, F. (2015) · Tumor Biology · doi:10.1007/s13277-015-4623-4 · Cited by 52
Noncoding RNA and colorectal cancer: its epigenetic role
Kita, Y., Yonemori, K., Osako, Y., Baba, K., Mori, S., Maemura, K., & Natsugoe, S. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.66 · Cited by 53
Xie, C., Liu, Y., Lan, L., Wei, H. Y., & Dong, W. (2020) · Aging · doi:10.18632/aging.103319 · Cited by 52
Meza‐Sosa, K. F., Miao, R., Navarro, F., Zhang, Z., Zhang, Y., Hu, J. J., Hartford, C. C. R., Li, X. L., Pedraza‐Alva, G., Pérez‐Martínez, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.01.001 · Cited by 53
Jha, N. K., Arfin, S., Jha, S. K., Kar, R., Dey, A., Gundamaraju, R., Ashraf, G. M., Gupta, P. K., Dhanasekaran, S., Abomughaid, M. M., et al. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.022 · Cited by 54
Cao, J., Yan, X., Liu, T., Han, X., Yu, J., Liu, S., & Wang, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6600 · Cited by 51
Rodriguez, J. A., Huerta‐Yépez, S., Law, I. K. M., Baay-Guzman, G. J., Tirado-Rodríguez, B., Hoffman, J. M., Iliopoulos, D., Hommes, D. W., Verspaget, H. W., Chang, L., et al. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.08.001 · Cited by 50
Han, J., & Theiss, A. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000180 · Cited by 52
Jin, X., Ren, S., Macarak, E. J., & Rosenbloom, J. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.01.017 · Cited by 50
miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis
Song, C., Lu, P., Sun, G., Yang, L., Wang, Z., & Wang, Z. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.037 · Cited by 50
Öner, M. G., Rokavec, M., Kaller, M., Bouznad, N., Horst, D. A., Kirchner, T., & Hermeking, H. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.011 · Cited by 50
Self-citationNie, D., Fu, J., Chen, H., Chen, H., & Fu, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040861 · Cited by 51
Chiang, C., Goswami, S., Frissora, F. W., Xie, Z., Yan, P. S., Bundschuh, R. A., Walker, L. A., Huang, X., Mani, R., Mo, X. M., et al. (2019) · Blood · doi:10.1182/blood.2018882290 · Cited by 50
STAT3 Contributes to Radioresistance in Cancer
Wang, X., Zhang, X., Qiu, C., & Yang, N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01120 · Cited by 50
The p53/microRNA connection in gastrointestinal cancer
Hermeking, H., Rokavec, M., Li, H., & Jiang, L. (2014) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s43738 · Cited by 54
Self-citationXu, L., Li, X., Cai, M., Chen, J., Li, X., Wu, W. K. K., Kang, W., TONG, J. H. M., To, K., Guan, X., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308257 · Cited by 49
Park, J. H., van Wyk, H., McMillan, D. C., Quinn, J. A., Clark, J., Roxburgh, C. S. D., Horgan, P. G., & Edwards, J. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1416 · Cited by 49
Yuan, Y.-Y., Xi, Y., Chen, J.-Y., Zhu, P., Kang, J., Zou, Z.-Q., Wang, F.-Y., & Bu, S.-Z. (2017) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2016.12.042 · Cited by 49
Li, X., Li, J., Cai, Y., Peng, S., Wang, J., Xiao, Z., Wang, Y., Tao, Y., Li, J., Leng, Q., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.031 · Cited by 48
Resveratrol inhibits Interleukin-6 induced invasion of human gastric cancer cells
Yang, T., Zhang, J., Zhou, J., Zhu, M., Wang, L., & Yan, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.01.153 · Cited by 48
Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
Semenov, O., Daks, A. A., Fedorova, O., Shuvalov, O. Y., & Barlev, N. A. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.928399 · Cited by 47
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis
Lin, X., Chen, L., Yao, Y., Zhao, R., Cui, X., Chen, J., Hou, K., Zhang, M., Su, F., Chen, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4107 · Cited by 47
Zhang, X., Bai, J., Yin, H., Long, L., Zheng, Z., Wang, Q., Chen, F., Yu, X., & Zhou, Y. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12765 · Cited by 47
RetractedZNF281/ZBP-99: a new player in epithelial–mesenchymal transition, stemness, and cancer
Hahn, S., & Hermeking, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1160-3 · Cited by 47
Self-citationRen, W., Shen, S., Sun, Z., Shu, P., Shen, X., Bu, C., Ai, F., Zhang, X., Tang, A., Tian, L., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.02.055 · Cited by 46
STAT3 is Overactivated in Gastric Cancer Stem-Like Cells.
Hajimoradi, M., Hassan, Z. M., Ebrahimi, M., Soleimani, M., Bakhshi, M., Firouzi, J., & Samani, F. S. (2016) · PubMed Central · doi:10.22074/cellj.2016.3834 · Cited by 46
The relationship between microRNAs and the STAT3-related signaling pathway in cancer
Zhang, L., Li, J., Wang, Q., Meng, G., Lv, X., Zhou, H., Li, W., & Zhang, J. (2017) · Tumor Biology · doi:10.1177/1010428317719869 · Cited by 46
Chen, X., Tong, C., Li, H., Peng, W., Li, R., Luo, X., Ge, H., Ran, Y., Qin, L., Liu, Y., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10250 · Cited by 46
Self-citationLin, K., Jiang, H., Zhang, L., Jiang, Y., Yang, Y., Qiu, G., She, Y., Zheng, J., Chen, C., Fang, L., et al. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5127-z · Cited by 46
Cinobufagin suppresses colorectal cancer growth via STAT3 pathway inhibition.
Bai, Y., Wang, X., Cai, M., Ma, C., Xiang, Y., Hu, W., Zhou, B., Zhao, C., Dai, X., Li, X., et al. (2021) · PubMed Central · Cited by 45
Byun, W. S., Lim, H., Hong, J., Bae, E. S., Lee, S. B., Kim, Y., Lee, J., Lee, S. K., & Hong, S. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01115 · Cited by 45
Hu, Q., Wang, K., Sun, X. D., Li, Y., Fu, Q., Liang, T., & Tang, G. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.07.016 · Cited by 45
GATA6 suppresses migration and metastasis by regulating the miR-520b/CREB1 axis in gastric cancer
Liu, H., Du, F., Sun, L., Wu, Q., Wu, J., Tong, M., Wang, X., Wang, Q., Cao, T., Gao, X., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1270-x · Cited by 45
DC-SIGN–LEF1/TCF1–miR-185 feedback loop promotes colorectal cancer invasion and metastasis
Yuan, M.-L., Zhang, X.-S., Zhang, J., Wang, K., Zhang, Y., Shang, W., Zhang, Y.-N., Cui, J.-Y., Shi, X., Na, H., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0361-2 · Cited by 45
Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells
Shirmohamadi, M., Eghbali, E., Najjary, S., Mokhtarzadeh, A., Baghbanzadeh, A., Hajiasgharzadeh, K., Lotfinezhad, P., & Baradaran, B. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29042 · Cited by 44
Aryappalli, P., Shabbiri, K., Masad, R. J., Al-Marri, R. H., Haneefa, S. M., Mohamed, Y. A., Arafat, K., Attoub, S., Cabral-Marques, O., Ramadi, K. B., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184340 · Cited by 45
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis
Vezzani, B., Carinci, M., Previati, M., Giacovazzi, S., Sala, M. D., Gafà, R., Lanza, G., Wieckowski, M. R., Pinton, P., & Giorgi, C. (2022) · Cancers · doi:10.3390/cancers14051221 · Cited by 50
Tan, Z., Sun, W., Li, Y., Jiao, X., Zhu, M., Zhang, J., Chen, Q., & Jia, Y. (2022) · Biomolecules · doi:10.3390/biom12121723 · Cited by 44
Ma, J., Zeng, F., Ma, C., Pang, H., Fang, B., Lian, C., Yin, B., Zhang, X., Wang, Z., & Xia, J. (2016) · PubMed Central · Cited by 44
MicroRNAs as Key Effectors in the p53 Network
Goeman, F., Strano, S., & Blandino, G. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.003 · Cited by 44
Xu, S., Liu, Z., Lv, M., Chen, Y., & Liu, Y. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz019 · Cited by 46
Menéndez-Menéndez, J., Hermida‐Prado, F., Granda‐Díaz, R., González, A., Garcia-Pedrero, J. M., Del-Río-Ibisate, N., González-González, A., Cos, S., Alonso‐González, C., & Martínez‐Campa, C. (2019) · Cancers · doi:10.3390/cancers11071011 · Cited by 44
Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
Sakamoto, S., Kagawa, S., Kuwada, K., Ito, A., Kajioka, H., Kakiuchi, Y., Watanabe, M., Kagawa, T., Yoshida, R., Kikuchi, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1671760 · Cited by 44
Qu, Y., He, Y., Yang, Y., Li, Y., An, W., Li, Z., Wang, X. L., Han, Z., & Qin, L. (2020) · Journal of Cancer · doi:10.7150/jca.40171 · Cited by 44
miRNA signaling networks in cancer stem cells
Yoshida, K., Yamamoto, Y., & Ochiya, T. (2021) · Regenerative Therapy · doi:10.1016/j.reth.2021.01.004 · Cited by 44
MicroRNA-34a inhibits human trophoblast cell invasion by targeting MYC
Sun, M., Chen, H., Liu, J., Tong, C., & Meng, T. (2015) · BMC Cell Biology · doi:10.1186/s12860-015-0068-2 · Cited by 44
Chen, N., Uddin, B., Voit, R., & Schiebel, E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515605113 · Cited by 44
Regulation of the Function and Expression of EpCAM
Xiao, D., Xiong, M., Wang, X. W., Lyu, M., Sun, H., Cui, Y., Chen, C., Jiang, Z., & Sun, F. (2024) · Biomedicines · doi:10.3390/biomedicines12051129 · Cited by 45
Hu, X., Chen, P., Wu, Y. R., Wang, K., Xu, Y., Chen, H., Zhang, L., Wu, R., Webster, K. A., Yu, H., et al. (2016) · Stem Cells · doi:10.1002/stem.2391 · Cited by 43
Macrophages in tumor cell migration and metastasis
Friedman, M., Karagiannis, G. S., Condeelis, J. S., Oktay, M. H., & Entenberg, D. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1494462 · Cited by 47
Yuan, J. X., Li, Y., Zhang, H., Beeraka, N. M., Zhang, D., Wang, Q., Wang, M., Hemanth Vikram, P. R., Sethi, G., & Wang, G. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117714 · Cited by 47
RetractedIsoprenaline induces epithelial–mesenchymal transition in gastric cancer cells
Lu, Y., Geng, Z., Sun, X., Li, Y., Fu, X., Zhao, X., & Wei, B. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2477-0 · Cited by 42
Tomasi, M. L., Cossu, C., Spissu, Y., Floris, A., Ryoo, M., Iglesias–Ara, A., Wang, Q., Pandol, S. J., Bhowmick, N. A., Seki, E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20234 · Cited by 42
CDX2 is involved in microRNA‑associated inflammatory carcinogenesis in gastric cancer
Saito, M., Okayama, H., Saito, K., Ando, J., Kumamoto, K., Nakamura, I., Ohki, S., Ishi, Y., & Takenoshita, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.6956 · Cited by 41
Metastasis organotropism in colorectal cancer: advancing toward innovative therapies
He, K., Wang, Z., Luo, M., Li, B., Ding, N., Li, L., He, B., Wang, H., Cao, J., Huang, C., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04460-5 · Cited by 45
Wang, C., Wang, X., Zhang, D., Sun, X., Wu, Y., Wang, J., Li, Q., & Jiang, G. (2023) · Oncology Reports · doi:10.3892/or.2023.8627 · Cited by 43
Noncoding RNAs in Cancer Development
Lin, C., & He, L. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-034443 · Cited by 42
Regulatory miRNAs in Colorectal Carcinogenesis and Metastasis
Guo, Y., Bao, Y., & Yang, W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040890 · Cited by 41
Jiang, C., Zhang, Q., Shanti, R. M., Shi, S., Chang, T.-H., Carrasco, L., Alawi, F., & Le, A. D. (2017) · Stem Cells · doi:10.1002/stem.2666 · Cited by 41
Wu, J., Chen, J., Xi, Y., Wang, F., Sha, H., Luo, L., Zhu, Y., Hong, X., & Bu, S. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6189 · Cited by 41
Ieda, T., Tazawa, H., Okabayashi, H., Yano, S., Shigeyasu, K., Kuroda, S., Ohara, T., Noma, K., Kishimoto, H., Nishizaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52816-z · Cited by 40
Yu, J., Zhou, Z., Wei, Z.-W., Wu, J., Ouyang, J., Huang, W., He, Y., & Zhang, C. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100841 · Cited by 41
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
Sajjadi-Dokht, M., Mohammad, T. A. M., Rahman, H. S., Maashi, M. S., Danshina, S. D., Shomali, N., Solali, S., Marofi, F., Zeinalzadeh, E., Akbari, M., et al. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.10.009 · Cited by 41
Ma, Z., Sun, Q., Zhang, C., Zheng, Q., Liu, Y., Xu, H., He, Y., Yao, C., Chen, J., & Xia, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81972 · Cited by 40
Szczepanek, J., & Tretyn, A. (2023) · Biomolecules · doi:10.3390/biom13111590 · Cited by 43
MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review
Maroof, H., Salajegheh, A., Smith, R. A., & Lam, A. K.-Y. (2014) · Current Cancer Drug Targets · doi:10.2174/1568009614666141020100337 · Cited by 40
Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis
Zhao, Z., Wang, S., Lin, Y., Miao, Y., Zeng, Y., Nie, Y., Guo, P., Jiang, G., & Wu, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.6034 · Cited by 41
Zhang, T., Liu, L., Wei, L., Zeng, Y., Xu, H., Lan, Q., Su, P., & Chu, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7049 · Cited by 40
SNORA71A Promotes Colorectal Cancer Cell Proliferation, Migration, and Invasion
Zhang, Z., Tao, Y., Hua, Q., Cai, J., Ye, X., & Li, H. (2020) · BioMed Research International · doi:10.1155/2020/8284576 · Cited by 40
Self-citationAdditive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis
Gatsiou, A., Georgiopoulos, G. A., Vlachogiannis, N. I., Pfisterer, L., Fischer, A., Sachse, M., Laina, A., Bonini, F., Delialis, D., Tual‐Chalot, S., et al. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.05.005 · Cited by 40
Self-citationEpigenetic Signaling of Cancer Stem Cells During Inflammation
Liu, Z., Ren, Y., Meng, L., Li, L., Beatson, R., Deng, J., Zhang, T., Liu, J., & Han, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.772211 · Cited by 42
CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation
Zhao, G., Xu, Y., Weng, S., Zhang, S., Chen, Y., Shen, X., Dong, L., & Chen, S. (2019) · Oncogene · doi:10.1038/s41388-019-0740-7 · Cited by 39
SNRPB promotes cervical cancer progression through repressing p53 expression
Zhu, L., Zhang, X., & Sun, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109948 · Cited by 40
Zhang, Z., Sun, C., Li, C., Jiao, X., Griffin, B. B., Dongol, S., Wu, H., Zhang, C., Cao, W., Dong, R., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00453 · Cited by 39
Chen, Y., Li, J., Xiao, J.-K., Xiao, L., Xu, B., & Li, C. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01780-8 · Cited by 39
Wan, G., Xie, M., Yu, H., & Chen, H. (2018) · Innate Immunity · doi:10.1177/1753425918801496 · Cited by 39
Huang, Q., Li, S., Zhang, L., Qiao, X., Zhang, Y., Zhao, X., Xiao, G., & Li, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00461 · Cited by 38
Ge, X., Peng, X., Li, M., Ji, F., Chen, J., & Zhang, D. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153580 · Cited by 40
miR-34a is a microRNA safeguard for Citrobacter-induced inflammatory colon oncogenesis
Wang, L., Wang, E., Wang, Y., Mines, R. C., Xiang, K., Sun, Z., Zhou, G., Chen, K., Rakhilin, N., Chao, S., et al. (2018) · eLife · doi:10.7554/elife.39479 · Cited by 39
Research Progress on the Relationship Between Inflammation and Colorectal Cancer
Zhang, F., & Qiao, S. L. (2021) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12517 · Cited by 37
Kaller, M., & Hermeking, H. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-42059-2_4 · Cited by 36
Self-citationHosseini, M., Baghaei, K., Amani, D., & Ebtekar, M. (2021) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-021-00400-0 · Cited by 37
In vivo therapeutic genome editing via CRISPR/Cas9 magnetoplexes for myocardial infarction
Park, H., Kim, D., Cho, B., Byun, J., Kim, Y. S., Ahn, Y., Hur, J., Oh, Y., & Kim, J. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121327 · Cited by 37
Colorectal cancer and therapy response: a focus on the main mechanisms involved
Tirendi, S., Marengo, B., Domenicotti, C., Bassi, A. M., Almonti, V., & Vernazza, S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1208140 · Cited by 37
Huang, Z., Kaller, M., & Hermeking, H. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01193-2 · Cited by 38
Self-citationHur, K. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.4.007 · Cited by 36
Resveratrol inhibits hypoxia-induced glioma cell migration and invasion by the p-STAT3/miR-34a axis
WANG, H., FENG, H., & ZHANG, Y. (2016) · Neoplasma · doi:10.4149/neo_2016_406 · Cited by 38
Misso, G., Zarone, M. R., Lombardi, A., Grimaldi, A., Cossu, A. M., Ferri, C., Russo, M., Vuoso, D. C., Luce, A., Kawasaki, H., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.02.023 · Cited by 38
Silencing of p68 and STAT3 synergistically diminishes cancer progression.
Hashemi, V., Ahmadi, A., Malakotikhah, F., Chaleshtari, M. G., Moornani, M. B., Masjedi, A., Sojoodi, M., Atyabi, F., Nikkhoo, A., Rostami, N., et al. (2020) · Life Science · doi:10.1016/j.lfs.2020.117499 · Cited by 29
RetractedMechanisms of resveratrol in the prevention and treatment of gastrointestinal cancer
Wang, L., Zhao, S., Lv, G.-J., Ma, X., & Zhang, J.-B. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i12.2425 · Cited by 36
Metadata
- Authors
- Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., Slotta-Huspenina, J., Bader, F. G., Greten, F. R., & Hermeking, H.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Universitätsmedizin Göttingen (DE)
- German Cancer Research Center (DE)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2014-03-18
- Volume
- 124
- Issue
- 4
- Pages
- 1853-1867
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3973098
- OpenAlex
- W2104268053
- Cited by
- 753
- References
- 66
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 60 · 2023: 66 · 2022: 90 · 2021: 69 · 2020: 66 · 2019: 76 · 2018: 59 · 2017: 69 · 2016: 65 · 2015: 66 · 2014: 20
- FWCI
- 23.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- GRO (submittedVersion)
- Funders
- Johns Hopkins University (HCT116)
- Deutsche Forschungsgemeinschaft
- Deutsche Krebshilfe
- Deutschen Konsortium für Translationale Krebsforschung
- FP7 Ideas: European Research Council (281967)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- colorectal cancer, epithelial-mesenchymal transition, interleukin-6, IL-6 receptor, STAT3, miR-34a, feedback loops, tumor invasion, metastasis, p53, snails, microRNA regulation
- MeSH terms
- Snail Family Transcription Factors, Animals, Disease Models, Animal, Female, Humans, Male, Neoplasm Invasiveness, Neoplasm Metastasis, Transcription Factors, Colorectal Neoplasms, Mice, Knockout, Receptors, Interleukin-6, Feedback, Physiological, MicroRNAs, Cell Line, Tumor, STAT3 Transcription Factor, Mice, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review